FDAFDA · Food and drugs·Recall number D-1340-2014
XZEN PLATINUM, 750 mg, Distributed by: XZEN, Los Angeles, CA.
Published May 28, 2014 · Recall initiated: January 9, 2014
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil.
What to do
Voluntary: Firm initiated · Press Release
Recall details
- Manufacturer
- Schindele Enterprises dba Midwest Wholesale
- Distributor
- Distributed to PA, IL, TX, IA, GA, CT, FL, CA, LA, NY, MD, NV, and WI
- Lot
- Lot 130520PL Exp. 05/31/2017
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.